Lian G - Search Results

1

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors.

Lian G, Mak TS, Yu X, Lan HY. Lian G, et al. Int J Mol Sci. 2021 Dec 23;23(1):164. doi: 10.3390/ijms23010164. Int J Mol Sci. 2021. PMID: 35008589 Free PMC article. Review.

2

Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.

Tang PM, Zhou S, Meng XM, Wang QM, Li CJ, Lian GY, Huang XR, Tang YJ, Guan XY, Yan BP, To KF, Lan HY. Tang PM, et al. Nat Commun. 2017 Mar 6;8:14677. doi: 10.1038/ncomms14677. Nat Commun. 2017. PMID: 28262747 Free PMC article.

3

The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring.

Tang PM, Zhou S, Li CJ, Liao J, Xiao J, Wang QM, Lian GY, Li J, Huang XR, To KF, Ng CF, Chong CC, Ma RC, Lee TL, Lan HY. Tang PM, et al. Kidney Int. 2018 Jan;93(1):173-187. doi: 10.1016/j.kint.2017.07.026. Epub 2017 Oct 14. Kidney Int. 2018. PMID: 29042082 Free article.

4

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro.

Tang PM, Tang PC, Chung JY, Hung JSC, Wang QM, Lian GY, Sheng J, Huang XR, To KF, Lan HY. Tang PM, et al. J Vis Exp. 2018 Jan 9;(131):56785. doi: 10.3791/56785. J Vis Exp. 2018. PMID: 29364233 Free PMC article.

5

Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells.

Wang QM, Tang PM, Lian GY, Li C, Li J, Huang XR, To KF, Lan HY. Wang QM, et al. Cancer Immunol Res. 2018 Aug;6(8):965-977. doi: 10.1158/2326-6066.CIR-17-0491. Epub 2018 Jun 18. Cancer Immunol Res. 2018. PMID: 29915022

6

Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling.

Lian GY, Wang QM, Tang PM, Zhou S, Huang XR, Lan HY. Lian GY, et al. Mol Ther. 2018 Sep 5;26(9):2255-2266. doi: 10.1016/j.ymthe.2018.06.016. Epub 2018 Jun 22. Mol Ther. 2018. PMID: 30017880 Free PMC article.

7

The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages.

Li C, Xue VW, Wang QM, Lian GY, Huang XR, Lee TL, To KF, Tang PM, Lan HY. Li C, et al. Cancer Immunol Res. 2020 Aug;8(8):1004-1017. doi: 10.1158/2326-6066.CIR-19-0782. Epub 2020 Jun 12. Cancer Immunol Res. 2020. PMID: 32532809

8

Discovery of a novel selective water-soluble SMAD3 inhibitor as an antitumor agent.

Wu N, Lian G, Sheng J, Wu D, Yu X, Lan H, Hu W, Yang Z. Wu N, et al. Among authors: lian g. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127396. doi: 10.1016/j.bmcl.2020.127396. Epub 2020 Jul 9. Bioorg Med Chem Lett. 2020. PMID: 32738967

9

Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin.

Lian GY, Wang QM, Mak TS, Huang XR, Yu XQ, Lan HY. Lian GY, et al. Mol Ther Oncolytics. 2021 Jan 20;20:277-289. doi: 10.1016/j.omto.2021.01.006. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33614911 Free PMC article.

10

Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.

Lian GY, Wan Y, Mak TS, Wang QM, Zhang J, Chen J, Wang ZY, Li M, Tang PM, Huang XR, Lee CS, Yu XQ, Lan HY. Lian GY, et al. Biomaterials. 2022 Sep;288:121730. doi: 10.1016/j.biomaterials.2022.121730. Epub 2022 Aug 12. Biomaterials. 2022. PMID: 35995622 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters